Table 1 Concordance between ELISA and luciferase-based assay results, with patient and control demographics.

From: Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies

ID

Diagnosis

Age

Sex

WNV-NTAbs

IFN-α2 10 RLA Ratio (%)

IFN-β 10 RLA Ratio (%)

IFN-ω 10 RLA Ratio (%)

IFN-α2 100 RLA Ratio (%)

IFN-ω 100 RLA Ratio (%)

IFN-β 1 RLA Ratio (%)

OD Anti-α2_ELISA

OD Anti-β_ELISA

OD Anti-ω_ELISA

Summary_results_ELISA

AAb + /- (ELISA)

IFN-I-NTAbs

IFN-I-NTAbs ARPE Assay

S04

WNND

75

M

 < 1:10

2.5

28.0

2.8

4.6

2.6

10.2

3.5

0.5

0.5

α2

AAb + 

Pos

α2 Pos > 10,000 pg/mL

S06

WNND

71

M

1:10

0.6

16.5

2.2

1.6

2.6

55.0

3.4

0.1

0.3

α2

AAb + 

Pos

α2 Pos > 10,000 pg/mL

S07

WNND

79

F

1:10

1.6

47.3

1.3

6.5

11.5

18.4

3.5

0.6

2.0

α2;β;ω

AAb + 

Pos

α2 Pos > 500 pg/mL

S10

WNND

72

M

1:20

2.8

168.2

3.3

11.8

11.4

88.3

3.5

0.3

1.1

α2,ω

AAb + 

Pos

α2 Pos > 10,000 pg/mL

S11

WNND

62

M

1:40

2.2

84.6

2.7

12.5

7.0

34.3

3.5

0.4

1.0

α2,ω

AAb + 

Pos

α2 Pos > 10,000 pg/mL

S18

WNND

90

M

1:40

2.0

68.4

1.3

3.3

2.8

57.3

2.3

0.5

1.6

α2,ω

AAb + 

Pos

ω Pos > 500 pg/mL

S22

WNND

93

F

1:10

1.3

48.1

1.3

3.8

3.5

10.2

1.9

1.1

1.0

α2;β;ω

AAb + 

Pos

ω Pos > 500 / β Pos > 100 pg/mL

S23

WNND

71

F

1:20

18.7

74.3

1.3

3.5

3.2

96.9

0.6

0.4

1.7

α2,ω

AAb + 

Pos

ω Pos > 500 pg/mL

S24

WNND

78

F

 < 1:10

2.5

90.6

1.6

4.2

4.1

100.0

2.3

0.4

1.4

α2,ω

AAb + 

Pos

ω Pos > 500 pg/mL

S21

WNND

56

M

1:40

57.6

74.9

47.4

55.0

44.8

70.2

0.1

0.1

1.1

No AAb

Neg

Neg

S25

WNND

61

F

 < 1:10

78.3

67.5

56.8

67.2

52.1

68.4

0.3

0.2

0.1

No AAb

Neg

Neg

N1

Healthy_blood_donor

61

M

1:10

81.6

76.4

66.1

71.4

72.6

73.0

0.3

0.5

0.2

No AAb

Neg

Neg

N2

Healthy_blood_donor

30

F

1:40

50.8

49.3

46.3

37.6

32.3

44.9

0.3

0.4

0.3

No AAb

Neg

Neg

N4

Healthy_blood_donor

55

M

1:10

54.3

93.5

58.6

54.7

30.5

67.4

0.2

0.2

0.1

No AAb

Neg

Neg